⌘K
Evotec
Deals on record
1
Common Fundraising Type
Seed
Aptadir Therapeutics
Biotech • Myelodysplastic Syndrome
Aptadir Therapeutics is a biotech company developing RNA-based inhibitors to treat Myelodysplastic Syndrome (MDS).
Deals on record
Common Fundraising Type
Biotech • Myelodysplastic Syndrome
Aptadir Therapeutics is a biotech company developing RNA-based inhibitors to treat Myelodysplastic Syndrome (MDS).